TAB-014

N/A

Report date: 2025/06/12 11:25:20

Base Information

Drug NameTAB-014
Drug Alias NameTAB014单抗注射液贝伐珠单抗眼内注射溶液（兆科）TAB-014
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesTot Biopharm International Company Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesLee’S Pharmaceutical Holdings LtdZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co LtdTot Biopharm Co Ltd
Inactive CompaniesLee'S Pharmaceutical Ltd
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A